Evaluation of contrast agents for enhanced visualization in optical coherence tomography

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 12, 2010, Pages 6614-6619

  Ehlers, Justis P ^a,b   Gupta, Preeya K ^b   Farsiu, Sina ^b   Maldonado, Ramiro ^b   Kim, Terry ^b   Toth, Cynthia A ^b   Mruthyunjaya, Prithvi ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b DUKE UNIVERSITY EYE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL TEAR; LIPID BASED ARTIFICIAL TEAR; PREDNISOLONE; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ANTERIOR EYE CHAMBER; ARTICLE; CADAVER; CATARACT EXTRACTION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORNEA EPITHELIUM; CORNEA INJURY; DATA ANALYSIS SOFTWARE; DRUG ADMINISTRATION ROUTE; IMAGE ANALYSIS; IMAGE ENHANCEMENT; IMAGE QUALITY; NONHUMAN; OPHTHALMOLOGY; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE STUDY; SWINE;

ANIMALS; ANTERIOR CHAMBER; CATARACT EXTRACTION; CONTRAST MEDIA; CORNEA; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; HUMANS; OPHTHALMIC SOLUTIONS; PREDNISOLONE; SWINE; TOMOGRAPHY, OPTICAL COHERENCE; TRIAMCINOLONE ACETONIDE; WOUND HEALING;

EID: 79955957641     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-6195     Document Type: Article

References (30)

1. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science. 1991;254:1178-1181.
2. Brezinski ME, Tearney GJ, Bouma BE, et al. Imaging of coronary artery microstructure (in vitro) with optical coherence tomography. Am J Cardiol. 1996;77:92-93.
3. D'Amico AV, Weinstein M, Li X, Richie JP, Fujimoto J. Optical coherence tomography as a method for identifying benign and malignant microscopic structures in the prostate gland. Urology. 2000;55:783-787.
4. Sivak MV Jr, Kobayashi K, Izatt JA, et al. High-resolution endoscopic imaging of the GI tract using optical coherence tomography. Gastrointest Endosc. 2000;51:474-479.
5. Welzel J, Lankenau E, Birngruber R, Engelhardt R. Optical coherence tomography of the human skin. J Am Acad Dermatol. 1997; 37:958-963.
6. Puliafito CA, Hee MR, Lin CP, et al. Imaging of macular diseases with optical coherence tomography. Ophthalmology. 1995;102: 217-229.
7. Schuman JS, Hee MR, Puliafito CA, et al. Quantification of nerve fiber layer thickness in normal and glaucomatous eyes using optical coherence tomography. Arch Ophthalmol. 1995;113:586-596.
8. Toth CA, Birngruber R, Boppart SA, et al. Argon laser retinal lesions evaluated in vivo by optical coherence tomography. Am J Ophthalmol. 1997;123:188-198.
9. Choma M, Sarunic M, Yang C, Izatt J. Sensitivity advantag of swept source and Fourier domain optical coherence tomography. Opt Express. 2003;11:2183-2189.
10. Leitgeb R, Hitzenberger C, Fercher A. Performance of Fourier domain vs. time domain optical coherence tomography. Opt Express. 2003;11:889-894.
11. de Boer JF, Cense B, Park BH, Pierce MC, Tearney GJ, Bouma BE. Improved signal-to-noise ratio in spectral-domain compared with time-domain optical coherence tomography. Opt Lett. 2003;28: 2067-2069.
12. Kiernan DF, Hariprasad SM, Chin EK, Kiernan CL, Rago J, Mieler WF. Prospective comparison of cirrus and stratus optical coherence tomography for quantifying retinal thickness. Am J Ophthalmol. 2009;147:267-275, e2.
13. Jones GE, Grohowski AL, et al. Iodinated organic compounds as contrast media for radiographic diagnoses; experimental studies on the visualization of the biliary tract. Radiology. 1948;51:225-236.
14. Laniado M, Weinmann HJ, Schorner W, Felix R, Speck U. First use of GdDTPA/dimeglumine in man. Physiol Chem Phys Med NMR. 1984;16:157-165.
15. Adler DC, Huang SW, Huber R, Fujimoto JG. Photothermal detection of gold nanoparticles using phase-sensitive optical coherence tomography. Opt Express. 2008;16:4376-4393.
16. Oldenburg AL, Applegate BE, Izatt JA, Boppart SA. Molecular optical coherence tomography contrast enhancement and imaging. In: Drexler W, Fujimoto JG, eds. Optical Coherence Tomography Technology and Applications. Berlin: Springer; 2008.
17. Wang RK, Elder JB. Propylene glycol as a contrasting agent for optical coherence tomography to image gastrointestinal tissues. Lasers Surg Med. 2002;30:201-208.
18. Sokolov K, Follen M, Aaron J, et al. Real-time vital optical imaging of precancer using anti-epidermal growth factor receptor antibodies conjugated to gold nanoparticles. Cancer Res. 2003;63:1999-2004.
19. Douma K, Prinzen L, Slaaf DW, et al. Nanoparticles for optical molecular imaging of atherosclerosis. Small. 2009;5:544-557.
20. Boppart SA. Advances in contrast enhancement for optical coherence tomography. Conf Proc IEEE Eng Med Biol Soc. 2006;1:121-124.
21. Boppart SA, Oldenburg AL, Xu C, Marks DL. Optical probes and techniques for molecular contrast enhancement in coherence imaging. J Biomed Opt. 2005;10:41208.
22. Grainger DW. Nanotoxicity assessment: all small talk? Adv Drug Deliv Rev. 2009;61:419-421.
23. Scott AW, Farsiu S, Enyedi LB, Wallace DK, Toth CA. Imaging the infant retina with a hand-held spectral-domain optical coherence tomography device. Am J Ophthalmol. 2009;147:364-373, e2.
24. Moshfeghi AA, Nugent AK, Nomoto H, Sanislo SR, Kitchens JW, Moshfeghi DM. Triamcinolone acetonide preparations: impact of crystal size on in vitro behavior. Retina. 2009;29:689-698.
25. Roberts CW, Nelson PL. Comparative analysis of prednisolone acetate suspensions. J Ocul Pharmacol Ther. 2007;23:182-187.
26. ® XP Emollient (Lubricant) Eye Drops. http://www.bausch.com/en_US/ecp/visioncare/product/drops/soothe.aspx. Accessed September 23, 2010.
27. Korb DR, Scaffidi RC, Greiner JV, et al. The effect of two novel lubricant eye drops on tear film lipid layer thickness in subjects with dry eye symptoms. Optom Vis Sci. 2005;82:594-601.
28. Kim CS, Wilder-Smith P, Ahn YC, Liaw LH, Chen Z, Kwon YJ. Enhanced detection of early-stage oral cancer in vivo by optical coherence tomography using multimodal delivery of gold nanoparticles. J Biomed Opt. 2009;14:034008.
29. Kirillin M, Shirmanova M, Sirotkina M, Bugrova M, Khlebtsov B, Zagaynova E. Contrasting properties of gold nanoshells and titanium dioxide nanoparticles for optical coherence tomography imaging of skin: Monte Carlo simulations and in vivo study. J Biomed Opt. 200914:021017.
30. Barton JK, Hoying JB, Sullivan CJ. Use of microbubbles as an optical coherence tomography contrast agent. Acad Radiol. 2002; 9(suppl 1):S52-S55.